Fuji Photo Film Co. said Monday it has become the leading shareholder in Tokyo drug venture Perseus Proteomics Inc. in a bid to push deeper into the medical business.
The move is part of an effort to branch out into new areas to make up for the slumping photo film business.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see this support page.
We humbly apologize for the inconvenience.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
SUBSCRIBE NOW
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.